Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Industrials
Leclanché has announced that it is working with the state-owned St. Kitts Electric Company (SKELEC) to build a solar generation plus storage project on the island of St. Kitts. Combining a 35.6MW solar farm and 44.2MWh battery storage facility, the project will be the largest in the Caribbean and Leclanché’s largest project so far. Given the scale of this project, our estimates remain under review until there is greater visibility on when different phases of the project are scheduled to complete.
Written by
Leclanché |
Major project in Caribbean |
Project award |
Renewable energy |
8 August 2019 |
Share price performance
Business description
Analyst
Leclanché is a research client of Edison Investment Research Limited |
||||||||||||||||||||||||||||
Leclanché has announced that it is working with the state-owned St. Kitts Electric Company (SKELEC) to build a solar generation plus storage project on the island of St. Kitts. Combining a 35.6MW solar farm and 44.2MWh battery storage facility, the project will be the largest in the Caribbean and Leclanché’s largest project so far. Given the scale of this project, our estimates remain under review until there is greater visibility on when different phases of the project are scheduled to complete.
Year end |
Revenue (CHFm) |
EBITDA |
PBT* |
EPS* |
DPS |
P/E |
12/17 |
18.0 |
(31.1) |
(37.8) |
(0.68) |
0.0 |
N/A |
12/18 |
48.7 |
(36.9) |
(47.8) |
(0.62) |
0.0 |
N/A |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
Renewables currently account for only 5–6% of the electricity produced on the island of St. Kitts, making it heavily reliant on imported fossil fuel, especially diesel, for power generation. The government is keen to reduce this dependence as global oil price fluctuations directly affect the cost of power, thus affecting household disposable incomes and GDP. It has approved the allocation of land for the project site and, through SKELEC, signed a 20-year power purchase agreement, securing cost-savings of between 20–25% compared with diesel generated power. Once completed, the new project will provide 25–30% of the island’s existing power generation requirements.
Together with local partner Solrid, Leclanché has set up a special purpose vehicle (SPV), financed by undisclosed third parties, with which it is in the final stages of negotiation. The SPV will fund, own and operate the facility. Leclanché will act as the prime engineering, procurement and construction contractor for the installation of both the solar photovoltaic system and the battery energy storage system (BESS). Once the project is completed and delivered, Leclanché will be responsible for management of all the project operations, maintenance and equipment warranties. This will be the largest project the company has worked on so far, the next largest being a 34.8MWh BESS in Cremzow, Germany, completed in FY18. We note Leclanché delivered c 50MWh capacity during FY18, generating CHF32.2m revenues from its Stationary segment.
|
|
Medigene continued its positive momentum in H119 announcing a new partnership (Roivant/Cytovant), expansion of its internal pipeline (MDG1021), sale of a legacy asset (Veregen) and progression of a partnered product (Bluebird MAGE-A4). Patient enrolment in Medigene’s MDG1011 trial in multiple myeloma (MM), acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) is ongoing and we forecast initial data in H120. The company reiterated its FY19 financial guidance of an EBITDA loss of €23–28m. We value Medigene at €458m (€18.65/share).